Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

MRI measures of Alzheimer's disease and the AddNeuroMed study.

Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C; AddNeuroMed Consortium.

Ann N Y Acad Sci. 2009 Oct;1180:47-55. doi: 10.1111/j.1749-6632.2009.05063.x.

PMID:
19906260
2.

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.

Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Wahlund LO, Soininen H, Lovestone S, Evans A, Spenger C.

Int J Geriatr Psychiatry. 2011 Jan;26(1):75-82. doi: 10.1002/gps.2491.

PMID:
21157852
3.

AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.

Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Oct 1;58(3):818-28. doi: 10.1016/j.neuroimage.2011.06.065. Epub 2011 Jul 1.

PMID:
21763442
4.

Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C, Rei L, Squarcia S, Rodriguez G, Bellotti R, Cerello P, De Mitri I, Retico A, Nobili F; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Sep 15;58(2):469-80. doi: 10.1016/j.neuroimage.2011.05.083. Epub 2011 Jun 16.

PMID:
21718788
5.

Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.

Westman E, Aguilar C, Muehlboeck JS, Simmons A.

Brain Topogr. 2013 Jan;26(1):9-23. doi: 10.1007/s10548-012-0246-x. Epub 2012 Aug 14.

6.

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.

Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium.

Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023. eCollection 2014.

7.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5.

PMID:
20447732
8.

Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis.

Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H; AddNeuroMed Consortium.

Neuroradiology. 2012 Sep;54(9):929-38. doi: 10.1007/s00234-012-1005-0. Epub 2012 Jan 14.

9.

The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.

Cavedo E, Redolfi A, Angeloni F, Babiloni C, Lizio R, Chiapparini L, Bruzzone MG, Aquino D, Sabatini U, Alesiani M, Cherubini A, Salvatore E, Soricelli A, Vernieri F, Scrascia F, Sinforiani E, Chiarati P, Bastianello S, Montella P, Corbo D, Tedeschi G, Marino S, Baglieri A, De Salvo S, Carducci F, Quattrocchi CC, Cobelli M, Frisoni GB.

J Alzheimers Dis. 2014;40(4):941-52. doi: 10.3233/JAD-132666.

PMID:
24577455
10.

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.

Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Nov 27;7:105-13. doi: 10.1016/j.nicl.2014.11.015. eCollection 2015.

11.

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2008 Sep;131(Pt 9):2443-54. doi: 10.1093/brain/awn146. Epub 2008 Jul 11.

12.

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.

Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; AddNeuroMed consortium.

J Intern Med. 2013 Jun;273(6):602-21. doi: 10.1111/joim.12037. Epub 2013 Feb 28.

13.

Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.

Andrade de Oliveira A, Carthery-Goulart MT, Oliveira Júnior PP, Carrettiero DC, Sato JR.

J Alzheimers Dis. 2015;43(1):201-12. doi: 10.3233/JAD-140189.

PMID:
25079801
14.

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.

Westman E, Muehlboeck JS, Simmons A.

Neuroimage. 2012 Aug 1;62(1):229-38. doi: 10.1016/j.neuroimage.2012.04.056. Epub 2012 May 3.

PMID:
22580170
15.

Comparison of manual and automated determination of hippocampal volumes in MCI and early AD.

Shen L, Saykin AJ, Kim S, Firpi HA, West JD, Risacher SL, McDonald BC, McHugh TL, Wishart HA, Flashman LA.

Brain Imaging Behav. 2010 Mar;4(1):86-95. doi: 10.1007/s11682-010-9088-x.

16.

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium.

Neurobiol Aging. 2011 Jul;32(7):1198-206. doi: 10.1016/j.neurobiolaging.2009.07.008. Epub 2009 Aug 14.

PMID:
19683363
17.

Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.

Suppa P, Hampel H, Spies L, Fiebach JB, Dubois B, Buchert R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;46(1):199-209. doi: 10.3233/JAD-142280.

PMID:
25720402
18.

Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.

Varon D, Barker W, Loewenstein D, Greig M, Bohorquez A, Santos I, Shen Q, Harper M, Vallejo-Luces T, Duara R; Alzheimer's Disease Neuroimaging Initiative.

Int J Geriatr Psychiatry. 2015 Feb;30(2):192-200. doi: 10.1002/gps.4126. Epub 2014 May 12.

PMID:
24816477
19.

Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.

Khondoker M, Newhouse S, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Dobson R, Simmons A; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;45(3):851-64. doi: 10.3233/JAD-142214.

PMID:
25649652
20.

Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.

Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 May 15;92:169-81. doi: 10.1016/j.neuroimage.2014.01.058. Epub 2014 Feb 9.

PMID:
24521851

Supplemental Content

Support Center